ART Selection in Treatment-Naive PWH: Weight Gain Considerations
Listen to this patient case from Princy N. Kumar MD, FIDSA, MACP, as she shares the latest data on weight gain after ART initiation.
Decera Clinical Education Infectious Disease Podcast · Princy N Kumar MD FIDSA MACP
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Princy N. Kumar, MD, FIDSA, MACP, discusses key considerations for selecting ART in treatment-naive persons with HIV. Her discussion includes a review of the following studies on ART and weight gain:
- ADVANCE: men vs women receiving DTG + FTC/TAF, DTG + FTC/TDF, and EFV + FTC/TDF
- Comparison of ART regimens (eg, INSTI-, NNRTI- and PI-based regimens) in a pooled analysis of 8 phase III randomized controlled trials
- GEMINI-1 and GEMINI-2: DTG + 3TC vs DTG + FTC/TDF
Presenter:
Princy N. Kumar, MD, FIDSA, MACP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC
Content based on an online CME program supported by an independent educational grant from ViiV Healthcare.
Link to full program:
https://bit.ly/3VIsDTg
Follow along with the slides:
https://bit.ly/3PYy1zn
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.